Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension

Micardis® in Patients With Essential Hypertension

NCT02187705 ·Status: COMPLETED

An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice

NCT00982735 ·Status: COMPLETED

Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)

NCT02262637 ·Status: COMPLETED

Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension

NCT02242370 ·Status: COMPLETED ·Phase: PHASE4

Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension

NCT02242838 ·Status: COMPLETED

Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension

NCT02245464 ·Status: COMPLETED

Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

NCT00879411 ·Status: COMPLETED

A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)

NCT02242396 ·Status: COMPLETED

Study to Evaluate the Trough and Peak Effect of Once Daily Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg (Micardis Plus) by Ambulatory Blood Pressure Monitoring (ABPM) in Patients With Mild to Moderate Essential Hypertension

NCT00257491 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension

NCT02177422 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension

NCT02242344 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients

NCT00904371 ·Status: COMPLETED

A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)

NCT00543413 ·Status: COMPLETED ·Phase: PHASE2

A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension

NCT00635232 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension

NCT00904215 ·Status: COMPLETED

Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

NCT02262611 ·Status: COMPLETED

MK0954 Versus Placebo for Treatment of Mild to Moderate Hypertension

NCT00888355 ·Status: COMPLETED ·Phase: PHASE3

PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg

NCT00936208 ·Status: COMPLETED

Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters

NCT00615108 ·Status: COMPLETED

Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan

NCT01108796 ·Status: COMPLETED

Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension

NCT00659607 ·Status: COMPLETED

A Study to Investigate the Antihypertensive Efficacy of MK0954

NCT00887250 ·Status: COMPLETED ·Phase: PHASE3

Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise

NCT00946829 ·Status: COMPLETED

A Study to Investigate the Efficacy and Safety of Different Doses of Losartan Potassium (MK0954-011)

NCT00882440 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Efficacy and Safety of HGP2102 in Essential Hypertension Patients

NCT06174766 ·Status: RECRUITING ·Phase: PHASE3